Literature DB >> 20061362

Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.

Shiby Paul1, Andrew J DeCastro, Hong Jin Lee, Amanda K Smolarek, Jae Young So, Barbara Simi, Chung Xiou Wang, Renping Zhou, Agnes M Rimando, Nanjoo Suh.   

Abstract

Stilbenes are phytochemicals present in grapes, berries, peanuts and red wine. A widely studied stilbene, resveratrol (trans-3,5,4'-trihydroxystilbene), has been shown to exert antioxidant, anti-inflammatory, chemopreventive and antiaging effects in a number of biological systems. We reported earlier that pterostilbene (trans-3,5-dimethoxy-4'-hydroxystilbene), a structurally related stilbene found in blueberries, was effective in reducing the incidence and multiplicity of aberrant crypt foci formation in the colon of rats injected with azoxymethane (AOM). Our present study was to identify the chemopreventive potential of pterostilbene with colonic tumor formation as an end point and further to evaluate the mechanistic action of pterostilbene during colon carcinogenesis. F344 rats were given two AOM injections subcutaneously when they were 7 and 8 weeks old and continuously fed the control or 40 p.p.m. pterostilbene diet for 45 weeks. Overall analyses indicated that pterostilbene reduced colon tumor multiplicity of non-invasive adenocarcinomas, lowered proliferating cell nuclear antigen and downregulated the expression of beta-catenin and cyclin D1. Pterostilbene decreased mucosal levels of the proinflammatory cytokines, tumor necrosis factor-alpha, interleukin (IL)-1beta and IL-4. Colon tumors from pterostilbene-fed animals showed reduced expression of inflammatory markers as well as nuclear staining for phospho-p65, a key molecule in the nuclear factor-kappaB pathway. In HT-29 cells, pterostilbene reduced the protein levels of beta-catenin, cyclin D1 and c-MYC, altered the cellular localization of beta-catenin and inhibited the phosphorylation of p65. Our data with pterostilbene in suppressing colon tumorigenesis, cell proliferation as well as key inflammatory markers in vivo and in vitro suggest the potential use of pterostilbene for colon cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061362      PMCID: PMC2899944          DOI: 10.1093/carcin/bgq004

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  50 in total

1.  Celecoxib for the prevention of colorectal adenomatous polyps.

Authors:  Nadir Arber; Craig J Eagle; Julius Spicak; István Rácz; Petr Dite; Jan Hajer; Miroslav Zavoral; Maria J Lechuga; Paola Gerletti; Jie Tang; Rebecca B Rosenstein; Katie Macdonald; Pritha Bhadra; Robert Fowler; Janet Wittes; Ann G Zauber; Scott D Solomon; Bernard Levin
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

2.  Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.

Authors:  Jun Yang; Wen Zhang; Paul M Evans; Xi Chen; Xi He; Chunming Liu
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

Review 3.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development.

Authors:  Murugan Sengottuvelan; Namasivayam Nalini
Journal:  Br J Nutr       Date:  2006-07       Impact factor: 3.718

Review 5.  Therapeutic potential of resveratrol: the in vivo evidence.

Authors:  Joseph A Baur; David A Sinclair
Journal:  Nat Rev Drug Discov       Date:  2006-05-26       Impact factor: 84.694

Review 6.  Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.

Authors:  D Pereg; M Lishner
Journal:  J Intern Med       Date:  2005-08       Impact factor: 8.989

Review 7.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anjana Bhardwaj; Rishi S Aggarwal; Navindra P Seeram; Shishir Shishodia; Yasunari Takada
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

8.  Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.

Authors:  Q S Wang; A Papanikolaou; C L Sabourin; D W Rosenberg
Journal:  Carcinogenesis       Date:  1998-11       Impact factor: 4.944

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.

Authors:  Stewart Sale; Richard G Tunstall; Ketan C Ruparelia; Gerry A Potter; William P Steward; Andreas J Gescher
Journal:  Int J Cancer       Date:  2005-06-10       Impact factor: 7.396

View more
  53 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth.

Authors:  Cassia S Mizuno; Shiby Paul; Nanjoo Suh; Agnes M Rimando
Journal:  Bioorg Med Chem Lett       Date:  2010-10-14       Impact factor: 2.823

3.  Phytochemicals and colorectal cancer prevention--myth or reality?

Authors:  Luigi Ricciardiello; Franco Bazzoli; Vincenzo Fogliano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-09-06       Impact factor: 46.802

Review 4.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

5.  Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.

Authors:  Tun-Chieh Chen; Ya-Ling Hsu; Yu-Chieh Tsai; Yu-Wei Chang; Po-Lin Kuo; Yen-Hsu Chen
Journal:  J Mol Med (Berl)       Date:  2013-09-05       Impact factor: 4.599

6.  Effects of pterostilbene in brown adipose tissue from obese rats.

Authors:  Leixuri Aguirre; Iñaki Milton-Laskibar; Elizabeth Hijona; Luis Bujanda; Agnes M Rimando; María P Portillo
Journal:  J Physiol Biochem       Date:  2017-02-27       Impact factor: 4.158

7.  Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases.

Authors:  Huan Shen; Guang Zeng; Guo Tang; Xingwei Cai; Lixia Bi; Changcheng Huang; Yongjin Yang
Journal:  Tumour Biol       Date:  2014-05-01

Review 8.  Antidepressant fluoxetine and its potential against colon tumors.

Authors:  Helga Stopper; Sergio Britto Garcia; Ana Maria Waaga-Gasser; Vinicius Kannen
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

9.  Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol.

Authors:  Ashley C Huderson; Jeremy N Myers; Mohammad S Niaz; Mary K Washington; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2012-08-11       Impact factor: 6.048

10.  Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions.

Authors:  Sandipan Chakraborty; Avinash Kumar; Nasir A Butt; Liangfen Zhang; Raquema Williams; Agnes M Rimando; Pradip K Biswas; Anait S Levenson
Journal:  Mol Biosyst       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.